Inventor · disambiguated record
Anthony B. Reed
Also filed as: REED ANTHONY · REED ANTHONY B
30 granted patents·10 pending applications·386 citations·filing 2005–2025
97Inventor score
Top patents by PatentIndex Score
40 records- 0198US11993597B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2022·Granted May 28, 2024·8 cites·50 claims
- 0298US11905281B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2020·Granted Feb 20, 2024·13 cites·16 claims
- 0398US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0498US11306087B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2020·Granted Apr 19, 2022·16 cites·55 claims
- 0598US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0698US10640504B2Inhibitors of KRAS G12C and methods of using the sameAMGEN INC·Filed 2018·Granted May 5, 2020·50 cites·71 claims
- 0798US10532042B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2017·Granted Jan 14, 2020·49 cites·13 claims
- 0898US10519146B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2018·Granted Dec 31, 2019·81 cites·33 claims
- 0997US11285135B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Mar 29, 2022·20 cites·16 claims
- 1096US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 1196US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 1294US7776869B2Heteroaryl-substituted alkyne compounds and method of useAMGEN INC·Filed 2005·Granted Aug 17, 2010·20 cites·15 claims
- 1393US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1490US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 1588US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1687US7635715B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Dec 22, 2009·7 cites·50 claims
- 1785US2025362134A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1884US2024174660A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2023·Application pending·0 cites
- 1984US2024287068A1Inhibitors of kras g12c and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 2082US7759337B2Phthalazine compounds and methods of useAMGEN INC·Filed 2006·Granted Jul 20, 2010·7 cites·14 claims
- 2182US2025057817A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2024·Application pending·0 cites
- 2280US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 2380US7582631B2Substituted heterocyclic compounds and methods of useAMGEN INC·Filed 2005·Granted Sep 1, 2009·5 cites·9 claims
- 2480US2024327461A1Apelin polypeptidesAMGEN INC·Filed 2024·Application pending·0 cites
- 2577US7842685B2S1P1 receptor agonists and use thereofAMGEN INC·Filed 2009·Granted Nov 30, 2010·3 cites·32 claims
- 2676US8048894B2Quinolones and azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2008·Granted Nov 1, 2011·2 cites·23 claims
- 2775US8030346B2Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activityAMGEN INC·Filed 2008·Granted Oct 4, 2011·2 cites·74 claims
- 2874US11807693B2Apelin polypeptidesAMGEN INC·Filed 2021·Granted Nov 7, 2023·0 cites·6 claims
- 2974US8048892B2Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2007·Granted Nov 1, 2011·2 cites·50 claims
- 3074US2022168280A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2022·Application pending·0 cites
- 3173US7569726B2Indanone derivatives that inhibit prolyl hydroxylaseAMGEN INC·Filed 2008·Granted Aug 4, 2009·1 cites·23 claims
- 3270US2020055845A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2019·Application pending·0 cites
- 3369US8349868B2Azaquinolones that inhibit prolyl hydroxylaseAMGEN INC·Filed 2011·Granted Jan 8, 2013·1 cites·25 claims
- 3461US7928139B2Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereofAMGEN INC·Filed 2009·Granted Apr 19, 2011·0 cites·30 claims
- 3559US10941182B2Apelin polypeptidesAMGEN INC·Filed 2015·Granted Mar 9, 2021·0 cites·26 claims
- 3657US2009149468A1Substituted heterocyclic compounds and methods of useAMGEN INC·Filed 2009·Application pending·0 cites
- 3749US11364248B2Compounds that inhibit Mcl-1 proteinAMGEN INC·Filed 2018·Granted Jun 21, 2022·0 cites·45 claims
- 3842US9394297B2Amides as pim inhibitorsAMGEN INC·Filed 2013·Granted Jul 19, 2016·0 cites·20 claims
- 3942US2007054916A1Aryl nitrogen-containing bicyclic compounds and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
- 4040US9321756B2Azole compounds as PIM inhibitorsWANG HUI-LING·Filed 2012·Granted Apr 26, 2016·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Anthony B. Reed files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →